Ligand snags Roche-partnered drug in Icagen buyout

Ligand snags Roche-partnered drug in Icagen buyout

Source: 
Fierce Biotech
snippet: 

Ligand Pharmaceuticals has acquired a Roche-partnered program from Icagen. The deal comes a little more than one year after Roche and Icagen entered into a drug discovery pact aimed at neurological disorders.